Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
- PMID: 25672854
- PMCID: PMC4331462
- DOI: 10.1186/s13054-014-0510-4
Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
Comment on
-
Albumin replacement in patients with severe sepsis or septic shock.N Engl J Med. 2014 Apr 10;370(15):1412-21. doi: 10.1056/NEJMoa1305727. Epub 2014 Mar 18. N Engl J Med. 2014. PMID: 24635772 Clinical Trial.
-
A word of caution regarding proposed benefits of albumin from ALBIOS: a dose of healthy skepticism.Crit Care. 2014 Sep 23;18(5):509. doi: 10.1186/s13054-014-0509-x. Crit Care. 2014. PMID: 25599371 Free PMC article. No abstract available.
References
-
- Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412–1421. doi: 10.1056/NEJMoa1305727. - DOI - PubMed
-
- O’Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, Newson J, Karra E, Winstanley A, Alazawi W, Garcia-Martinez R, Cordoba J, Nicolaou A, Gilroy DW. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014;20:518–523. doi: 10.1038/nm.3516. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical